Claude Benchimol has been appointed senior vice president of R&D, and John Carrino has been appointed chief scientist at Invitrogen. Benchimol was most recently vice president and general manager of global technology for General Electric’s Medical Systems IT division. He worked at GE in various leadership roles for a total of 15 years. Benchimol holds a master’s degree in engineering from École Nationale Superièure des Télécommunications in Paris, as well as a master’s and PhD in system science from the University of California Los Angeles. Carrino was previ-ously vice president of R&D for Invitrogen. He has also worked in R&D at Nanogen and Abbott Laboratories, and holds a PhD in microbiology and immunology from Northwestern University.
Catherine Burzik has been appointed executive vice president of Applied Biosystems. She was previously president of Ortho-Clinical Diagnostics, a subsidiary of Johnson & Johnson. Before that, she was general manager and vice president of Critikon, another Johnson & Johnson company.
Andrew Creasey has become president of NextGen Sciences Inc., the newly-formed Bedford, Mass.-based US subsidiary of Huntingdon, UK-based NextGen Sciences Ltd. Creasey was most recently director of marketing at Harvard Biosciences. Creasey holds a PhD in molecular genetics from the University of Newcastle-upon-Tyne, UK.
David Danley has been appointed director of homeland security and defense programs at CombiMatrix. Danley is a retired colonel for the US Army and was previously project manager of the Chemical Biological Medical Systems and Joint Vaccine Acquisition Program for the Department of Defense. Danley holds a BS in biology from Portland State University and a PhD in biological sciences from Purdue University.